image
Healthcare - Medical - Healthcare Plans - NYSE - US
$ 57.46
-2.08 %
$ 29 B
Market Cap
9.92
P/E
1. INTRINSIC VALUE

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services.[ Read More ]

The intrinsic value of one CNC stock under the base case scenario is HIDDEN Compared to the current market price of 57.5 USD, Centene Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CNC

image
FINANCIALS
154 B REVENUE
6.54%
2.93 B OPERATING INCOME
-19.42%
2.7 B NET INCOME
124.79%
8.05 B OPERATING CASH FLOW
28.62%
-1.19 B INVESTING CASH FLOW
59.23%
-1.66 B FINANCING CASH FLOW
60.50%
42 B REVENUE
5.49%
665 M OPERATING INCOME
-45.89%
710 M NET INCOME
-38.05%
-978 M OPERATING CASH FLOW
-44.97%
-839 M INVESTING CASH FLOW
28.11%
-1.24 B FINANCING CASH FLOW
-6.32%
Balance Sheet Decomposition Centene Corporation
image
Current Assets 40.8 B
Cash & Short-Term Investments 19.7 B
Receivables 0
Other Current Assets 21.1 B
Non-Current Assets 43.9 B
Long-Term Investments 16.3 B
PP&E 2.42 B
Other Non-Current Assets 25.2 B
Current Liabilities 36.7 B
Accounts Payable 16.3 B
Short-Term Debt 287 M
Other Current Liabilities 20.2 B
Non-Current Liabilities 22 B
Long-Term Debt 17.7 B
Other Non-Current Liabilities 4.26 B
EFFICIENCY
Earnings Waterfall Centene Corporation
image
Revenue 154 B
Cost Of Revenue 122 B
Gross Profit 31.5 B
Operating Expenses 28.6 B
Operating Income 2.93 B
Other Expenses 228 M
Net Income 2.7 B
RATIOS
20.48% GROSS MARGIN
20.48%
1.90% OPERATING MARGIN
1.90%
1.75% NET MARGIN
1.75%
10.46% ROE
10.46%
3.19% ROA
3.19%
5.03% ROIC
5.03%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Centene Corporation
image
Net Income 2.7 B
Depreciation & Amortization 1.29 B
Capital Expenditures -799 M
Stock-Based Compensation 216 M
Change in Working Capital 3.37 B
Others 780 M
Free Cash Flow 7.25 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Centene Corporation
image
Wall Street analysts predict an average 1-year price target for CNC of $87.7 , with forecasts ranging from a low of $72 to a high of $97 .
CNC Lowest Price Target Wall Street Target
72 USD 25.30%
CNC Average Price Target Wall Street Target
87.7 USD 52.57%
CNC Highest Price Target Wall Street Target
97 USD 68.81%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Centene Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
1.46 M USD 3
9-12 MONTHS
901 K USD 1
Bought
1.25 M USD 2
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
4 days ago
Nov 13, 2024
Bought 1 M USD
Asher Andrew Lynn
Chief Financial Officer
+ 17200
58.14 USD
1 week ago
Nov 08, 2024
Bought 250 K USD
LONDON SARAH
Chief Executive Officer
+ 4117
60.8 USD
6 months ago
May 14, 2024
Sell 67.4 K USD
COUGHLIN CHRISTOPHER J
Director
- 878
76.745 USD
6 months ago
May 13, 2024
Sell 621 K USD
FASOLA KENNETH J
President
- 8000
77.62 USD
9 months ago
Feb 13, 2024
Sell 774 K USD
Robinson Lori Jean
Director
- 10000
77.41 USD
9 months ago
Feb 07, 2024
Sell 613 K USD
FASOLA KENNETH J
President
- 8190
74.83 USD
9 months ago
Feb 07, 2024
Sell 288 K USD
FASOLA KENNETH J
President
- 3810
75.58 USD
1 year ago
Apr 27, 2023
Sell 93.2 K USD
Robinson Lori Jean
Director
- 1400
66.59 USD
1 year ago
Mar 17, 2023
Bought 1.88 M USD
LONDON SARAH
Chief Executive Officer
+ 30000
62.6 USD
1 year ago
Feb 10, 2023
Bought 273 K USD
Asher Andrew Lynn
EVP, CFO
+ 3800
71.97 USD
1 year ago
Feb 09, 2023
Bought 216 K USD
Asher Andrew Lynn
EVP, CFO
+ 3000
71.89 USD
1 year ago
Feb 08, 2023
Bought 495 K USD
MURRAY JAMES E
EVP, Chief Operating Officer
+ 6750
73.3 USD
1 year ago
Feb 08, 2023
Bought 503 K USD
Samuels Theodore R. II
Director
+ 7000
71.88 USD
2 years ago
Jul 29, 2022
Sell 830 K USD
BAGLEY SHANNON
EVP, Chief Admin. Officer
- 9000
92.21 USD
2 years ago
Jul 28, 2022
Sell 111 K USD
Robinson Lori Jean
director:
- 1200
92.77 USD
2 years ago
Jul 08, 2022
Sell 394 K USD
GEPHARDT Richard A
director:
- 4480
88 USD
2 years ago
Jun 21, 2022
Sell 264 K USD
GEPHARDT Richard A
Director
- 3300
80.01 USD
2 years ago
Jun 21, 2022
Sell 859 K USD
GEPHARDT Richard A
director:
- 10220
84.03 USD
2 years ago
Apr 29, 2022
Sell 648 K USD
BAGLEY SHANNON
EVP, Chief Admin. Officer
- 8000
80.99 USD
2 years ago
Apr 29, 2022
Bought 976 K USD
COUGHLIN CHRISTOPHER J
director:
+ 12000
81.37 USD
2 years ago
Apr 29, 2022
Bought 251 K USD
Dallas H James
director:
+ 3065
81.75 USD
2 years ago
Apr 28, 2022
Bought 507 K USD
Samuels Theodore R. II
director:
+ 6270
80.94 USD
2 years ago
Mar 24, 2022
Sell 305 K USD
BROOKS MARK J
EVP, Chief Information Officer
- 3690
82.71 USD
2 years ago
Jan 20, 2022
Sell 222 K USD
BROOKS MARK J
EVP, Chief Information Officer
- 2774
80 USD
2 years ago
Jan 11, 2022
Sell 310 K USD
THOMAS DAVID P
EVP, MARKETS
- 4000
77.61 USD
2 years ago
Dec 21, 2021
Sell 233 K USD
TONEY COLIN A
EVP, Mergers & Acquisitions
- 2807
82.94 USD
2 years ago
Dec 15, 2021
Sell 630 K USD
AYALA ORLANDO
Director
- 7586
82.99 USD
2 years ago
Dec 14, 2021
Sell 2.14 M USD
NEIDORFF MICHAEL F
Chairman & CEO
- 27000
79.37 USD
2 years ago
Dec 14, 2021
Sell 1.84 M USD
NEIDORFF MICHAEL F
Chairman & CEO
- 23000
80.11 USD
2 years ago
Dec 14, 2021
Sell 634 K USD
CASSO KATIE
SVP & Corporate Controller
- 8000
79.19 USD
3 years ago
Nov 10, 2021
Sell 1.5 M USD
ROBERTS JOHN R
Director
- 20000
75.04 USD
3 years ago
Oct 28, 2021
Sell 1.4 M USD
NEIDORFF MICHAEL F
Chairman & CEO
- 20000
70.09 USD
3 years ago
Oct 28, 2021
Sell 592 K USD
AYALA ORLANDO
Director
- 8430
70.17 USD
3 years ago
Oct 28, 2021
Sell 1.42 M USD
GEPHARDT Richard A
Director
- 20220
70 USD
3 years ago
Oct 28, 2021
Sell 582 K USD
BROOKS MARK J
EVP, Chief Information Officer
- 8296
70.17 USD
3 years ago
Oct 28, 2021
Sell 5.4 K USD
LAYTON BRENT D
President & COO
- 77
70.17 USD
3 years ago
Nov 01, 2021
Sell 277 K USD
LAYTON BRENT D
President & COO
- 3923
70.64 USD
3 years ago
Oct 28, 2021
Sell 1 M USD
KOSTER CHRISTOPHER
SVP, Secr. & General Counsel
- 14300
70.17 USD
3 years ago
Oct 11, 2021
Sell 212 K USD
GEPHARDT Richard A
Director
- 3300
64.13 USD
3 years ago
Jul 29, 2021
Sell 656 K USD
AYALA ORLANDO
Director
- 9366
70 USD
3 years ago
Jul 29, 2021
Sell 280 K USD
LAYTON BRENT D
EVP, Pres. HP, Products & Intl
- 4000
70 USD
3 years ago
Jun 15, 2021
Sell 2.07 M USD
AYALA ORLANDO
Director
- 30000
69.01 USD
3 years ago
Jun 11, 2021
Sell 1.78 M USD
Hunter Jesse N
EVP, M&A & Chief Strategy Ofcr
- 25000
71.17 USD
3 years ago
May 07, 2021
Sell 350 K USD
ROBERTS JOHN R
Director
- 5000
70 USD
3 years ago
May 07, 2021
Sell 1.02 M USD
BROOKS MARK J
EVP, Chief Information Officer
- 15000
68 USD
3 years ago
May 07, 2021
Sell 1.24 M USD
Schwaneke Jeffrey A.
EVP, HealthCare Enterprises
- 18000
69 USD
3 years ago
May 05, 2021
Sell 499 K USD
LAYTON BRENT D
EVP, Chief BD Officer
- 7682
65 USD
3 years ago
Apr 29, 2021
Sell 432 K USD
AYALA ORLANDO
Director
- 7201
60 USD
3 years ago
Mar 19, 2021
Sell 325 K USD
ROBERTS JOHN R
Director
- 5000
65 USD
3 years ago
Feb 26, 2021
Bought 9.94 K USD
DITMORE ROBERT K
Director
+ 170
58.45 USD
3 years ago
Feb 11, 2021
Sell 488 K USD
AYALA ORLANDO
Director
- 8000
60.97 USD
3 years ago
Jan 08, 2021
Sell 788 K USD
Hunter Jesse N
EVP, M&A & Chief Strategy Ofcr
- 11250
70 USD
3 years ago
Jan 06, 2021
Sell 536 K USD
BURKHALTER BRANDY
EVP, Chief Operating Officer
- 8000
67 USD
4 years ago
Nov 09, 2020
Sell 21 M USD
NEIDORFF MICHAEL F
Chairman, President & CEO
- 300000
70.12 USD
4 years ago
Nov 09, 2020
Sell 1.58 M USD
Hunter Jesse N
EVP, M&A & Chief Strategy Ofcr
- 22500
70 USD
4 years ago
Nov 09, 2020
Sell 2.46 M USD
Burdick Kenneth A
EVP, Markets & Products
- 35000
70.16 USD
4 years ago
Nov 05, 2020
Sell 536 K USD
BURKHALTER BRANDY
EVP, Chief Operating Officer
- 8000
67 USD
4 years ago
Nov 03, 2020
Sell 2.17 M USD
DITMORE ROBERT K
Director
- 33334
65.11 USD
4 years ago
Nov 02, 2020
Sell 2.17 M USD
Burdick Kenneth A
EVP, Markets & Products
- 35000
62.02 USD
4 years ago
Oct 29, 2020
Sell 542 K USD
AYALA ORLANDO
Director
- 8890
61 USD
4 years ago
Oct 05, 2020
Sell 2.17 M USD
Burdick Kenneth A
EVP, Markets & Products
- 35000
62 USD
4 years ago
Oct 01, 2020
Sell 87.5 K USD
Thompson Tommy G
Director
- 1500
58.36 USD
4 years ago
Aug 10, 2020
Sell 2.22 M USD
Burdick Kenneth A
EVP, Markets & Products
- 35000
63.33 USD
4 years ago
Jul 30, 2020
Sell 646 K USD
AYALA ORLANDO
Director
- 9878
65.36 USD
4 years ago
Jul 30, 2020
Sell 2.18 M USD
DITMORE ROBERT K
Director
- 33333
65.34 USD
4 years ago
Jul 30, 2020
Sell 2.31 M USD
Burdick Kenneth A
EVP, Markets & Products
- 35000
65.98 USD
4 years ago
Jul 01, 2020
Sell 96.2 K USD
Thompson Tommy G
Director
- 1500
64.13 USD
4 years ago
Jun 22, 2020
Sell 1.92 M USD
AYALA ORLANDO
Director
- 30000
63.87 USD
4 years ago
Jun 19, 2020
Sell 963 K USD
GEPHARDT Richard A
Director
- 14749
65.28 USD
4 years ago
Jun 16, 2020
Sell 676 K USD
GEPHARDT Richard A
Director
- 10401
65.02 USD
4 years ago
Jun 08, 2020
Sell 2.18 M USD
DITMORE ROBERT K
Director
- 33333
65.31 USD
4 years ago
Jun 08, 2020
Sell 2.31 M USD
Burdick Kenneth A
EVP, Markets & Products
- 35000
65.93 USD
4 years ago
Jun 08, 2020
Sell 536 K USD
BURKHALTER BRANDY
EVP, Chief Operating Officer
- 8000
67 USD
4 years ago
May 18, 2020
Sell 700 K USD
ROBERTS JOHN R
Director
- 10000
70 USD
7. News
3 Stocks Seeing Insider Buys: CNC, PFE, BMY Investors can see insider buys as an overall net positive concerning the longer-term outlook for a stock. zacks.com - 4 days ago
Sunshine Health Announces the Appointment of Charlene Zein as President and CEO PEMBROKE PINES, Fla. , Nov. 7, 2024  /PRNewswire/ -- Sunshine Health, Florida's largest managed care organization and a Centene Corporation company (NYSE: CNC), announced today Charlene Zein has been named Plan President and Chief Executive Officer, effective Nov. 3, 2024. prnewswire.com - 1 week ago
Trump Will Create New Winners and Losers in Healthcare Market reactions sharply diverged among healthcare companies as investors expect changes to Obamacare, Medicare. wsj.com - 1 week ago
Harris Stocks: Promising Picks If Harris Wins The Trump vs. Harris game is down to the bottom of the ninth. forbes.com - 1 week ago
Medicare Advantage Costs Surge: How These 2 Insurers Are Thriving Health insurers have been getting a lot of heat surrounding the rising costs of Medicare Advantage (MA) plans. Companies like CVS Health Co. NYSE: CVS have seen their medical benefits ratio (MBR) continue to rise, forecasting 90.8%, driven by the rising costs to provide MA plans to seniors. marketbeat.com - 1 week ago
CENTENE SUBSIDIARY BUCKEYE HEALTH PLAN AWARDED CONTRACT TO SERVE DUAL ELIGIBILE MEDICARE AND MEDICAID MEMBERS IN OHIO ST. LOUIS , Nov. 1, 2024 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its subsidiary, Buckeye Health Plan (Buckeye), has been selected by the Ohio Department of Medicaid (ODM) to continue providing Medicare and Medicaid services for dually eligible individuals through a Fully Integrated Dual Eligible Special Needs Plan (FIDE SNP). FIDE SNPs fully integrate care for dually eligible beneficiaries under a single managed care organization, allowing enrollees to receive all of their medical, behavioral and long-term services and supports through one plan. prnewswire.com - 2 weeks ago
AcariaHealth Shines at the 2024 NASP Annual Meeting: Transforming Specialty Pharmacy ORLANDO, Fla. , Oct. 30, 2024 /PRNewswire/ -- AcariaHealth, a leading national specialty pharmacy and a Centene Corporation company (NYSE: CNC), secured several recognitions during the 2024 National Association of Specialty Pharmacy (NASP) Annual Meeting held in Nashville, Tennessee, October 6-9. prnewswire.com - 2 weeks ago
AMBETTER OF ILLINOIS EXPANDS PROVIDER NETWORK TO INCLUDE ADVOCATE HEALTH CARE The addition of Advocate Health Care to the Ambetter of Illinois provider network offers its members expanded access to the health system's high-quality healthcare CHICAGO , Oct. 30, 2024 /PRNewswire/ -- Ambetter of Illinois (Ambetter), a product offered by Centene Corporation (NYSE: CNC), and managed locally by Meridian Health Plan of Illinois, Inc. (Meridian), announced today the addition of Advocate Health Care to its network, which will further increase members' access to quality healthcare in the Chicagoland area. Ambetter members can now receive care at any of Advocate's 11 hospitals and 300 sites of care in Illinois, with 6,500 physicians, and 11,000 nurses. prnewswire.com - 2 weeks ago
CENTENE NAMED ONE OF FORTUNE'S® 100 BEST LARGE WORKPLACES FOR WOMEN™ 2024 ST. LOUIS , Oct. 29, 2024 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it has been named to the 2024 Fortune 100 Best Large Workplaces for Women™ list for the second consecutive year. Ranking 66 out of 100 large companies, the list recognizes Centene for supporting employee well-being, fairness in compensation, and providing women in the workplace with ample opportunities for growth. prnewswire.com - 2 weeks ago
WHAT THEY ARE SAYING: 'Significant Positive Impact to Grants enable physicians to implement critical Department of Healthcare Services' Equity and Practice Transformation (EPT) Directed Payment Program SACRAMENTO, Calif. , Oct. 29, 2024 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and a company of Centene Corporation (NYSE: CNC), announced the awarding of $2 million in grants to 47 independent physician practices throughout California. prnewswire.com - 2 weeks ago
Superior HealthPlan Awards $26,000 in Grants to 13 Nonprofits and Providers The funding is made available through a quarterly program open to community-based organizations and providers across Texas. AUSTIN, Texas , Oct. 29, 2024 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene Corporation (NYSE: CNC), has announced the latest recipients of its quarterly community and provider grant program. prnewswire.com - 2 weeks ago
Centene Q3 Earnings Beat on Growth in Marketplace Business Line CNC's Q3 results benefit from growth in premiums, driven by strong product positioning. Despite higher revenues, declines in Medicaid membership and increased expenses weigh on profitability. zacks.com - 3 weeks ago
8. Profile Summary

Centene Corporation CNC

image
COUNTRY US
INDUSTRY Medical - Healthcare Plans
MARKET CAP $ 29 B
Dividend Yield 0.00%
Description Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Contact Centene Plaza, Saint Louis, MO, 63105 https://www.centene.com
IPO Date Dec. 13, 2001
Employees 67700
Officers Ms. Ashlee Knuckey Chief Risk, Ethics & Compliance Officer Ms. Jennifer Lynch Gilligan Senior Vice President of Investor Relations Ms. Sarah M. London Chief Executive Officer & Director Ms. Susan R. Smith Chief Operating Officer Mr. Andrew Lynn Asher Executive Vice President & Chief Financial Officer Mr. Kenneth John Fasola President Ms. Katie Nicole Casso Senior Vice President, Chief Accounting Officer & Corporate Controller Mr. Brian Phillip LeClaire M.B.A., Ph.D. Chief Information Officer Mr. David P. Thomas Chief Executive Officer of Markets & Medicaid Mr. Christopher Andrew Koster Executive Vice President, General Counsel & Secretary